Synopsys Company Profile (NASDAQ:SNPS)

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Synopsys declared that its Board of Directors has approved a share repurchase plan on Saturday, June 17th 2017, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Synopsys, Inc. (NASDAQ:SNPS) released its quarterly earnings results on Wednesday, August, 16th. The company reported $0.92 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.92. The company had revenue of $695.40 million for the quarter, compared to the consensus estimate of $691.22 million. Synopsys had a return on equity of 11.60% and a net margin of 12.37%. The company's revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.76 EPS. View Synopsys' Earnings History.

Synopsys is scheduled to release their next quarterly earnings announcement on Tuesday, November, 28th 2017. View Earnings Estimates for Synopsys.

Synopsys issued an update on its FY17 earnings guidance on Monday, September, 11th. The company provided earnings per share (EPS) guidance of $3.29-3.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.31. The company issued revenue guidance of $2.67-2.69 billion, compared to the consensus revenue estimate of $2.68 billion.Synopsys also updated its Q4 guidance to 0.55-0.58 EPS.

9 equities research analysts have issued 12 month price objectives for Synopsys' shares. Their forecasts range from $60.00 to $90.00. On average, they expect Synopsys' stock price to reach $83.00 in the next year. View Analyst Ratings for Synopsys.

Here are some recent quotes from research analysts about Synopsys stock:

• 1. According to Zacks Investment Research, "Synopsys is a vendor of electronic design automation (EDA) software to the semiconductor and electronics industries. Shares of Synopsys has outperformed the industry over the past one year. Synopsys recently completed the buyout of a privately-held self-funded company, QuantumWise. We believe that the company’s sustained focus on introducing new products, acquisitions and deal wins will continue to boost results, going ahead. Moreover, unique intellectual properties and global support provided by the company will likely drive its forthcoming results. Furthermore, Synopsys’ strategy to return wealth to shareholders highlights its growth potential and stable liquidity position. However, competition from peers, a challenging technology spending environment and uncertainty regarding the exact time of realizing acquisition synergies keep us on the side-lines." (10/3/2017)
• 2. Royal Bank Of Canada analysts commented, "Synopsys reported a solid quarter raising its full year guidance and generating 26.9% operating margins (highest margin profile since July 2009). In addition, the top line suggests 7%+ growth for the full year which should sustain double digit EPS growth' Synopsys reported upside to both the top and bottom line and generated operating margins of 26.9% which was the highest level since Jul-09 (over 7 years ago). While the full year numbers were only slightly modified (+$10M to both the low-end and highend) we think the margin profiles showcased the long-term potential for Synopsys. As the company continues to see revenues grow over the next several years, margins should expand in lock-step after digesting a set of acquisitions (Coverity then Cigital/Codiscope). With fundamentals continuing to improve we also highlight a solid cash balance sheet that can be utilized for continued share repurchases and strategic acquisitions as well. Net Net: the long-term potential for Synopsys continues to improve and we raise our price target to $77 (from $66)." (2/16/2017)

Some companies that are related to Synopsys include Red Hat (RHT), Citrix Systems (CTXS), Cadence Design Systems (CDNS), Atlassian Corporation PLC (TEAM), Splunk (SPLK), SS&C Technologies Holdings (SSNC), Tyler Technologies (TYL), National Instruments Corp (NATI), The Ultimate Software Group (ULTI), Micro Focus International plc (MCRO), Nuance Communications (NUAN), Blackbaud (BLKB), Solera Holdings (SLH), FireEye (FEYE), Playtech PLC (PTEC), CommVault Systems (CVLT), Paylocity Holding Corporation (PCTY) and Okta (OKTA).

Synopsys' management team includes the folowing people:

• Aart J. de Geus, Chairman of the Board, Co-Chief Executive Officer
• Chi-Foon Chan, President, Co-Chief Executive Officer, Director
• Trac Pham, Chief Financial Officer
• Joseph W. Logan, Executive Vice President - Worldwide Sales and Corporate Marketing
• John F. Runkel Jr., General Counsel and Corporate Secretary
• Steven C. Walske, Lead Independent Director
• Janice Durbin Chaffin, Independent Director
• Bruce R. Chizen, Independent Director
• Deborah A. Coleman, Independent Director
• Mercedes Johnson, Independent Director

Shares of Synopsys can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Synopsys stock can currently be purchased for approximately $83.72.